News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
710,262 Results
Type
Article (42060)
Company Profile (295)
Press Release (667907)
Section
Business (210241)
Career Advice (2086)
Deals (36606)
Drug Delivery (100)
Drug Development (82914)
Employer Resources (172)
FDA (16516)
Job Trends (15372)
News (355641)
Policy (33846)
Tag
Academia (2574)
Alliances (51289)
Alzheimer's disease (1316)
Approvals (16476)
Artificial intelligence (191)
Bankruptcy (364)
Best Places to Work (11750)
Biotechnology (188)
Breast cancer (216)
Cancer (1612)
Cardiovascular disease (129)
Career advice (1744)
CAR-T (111)
Cell therapy (324)
Clinical research (66583)
Collaboration (619)
Compensation (317)
COVID-19 (2626)
C-suite (143)
Data (1521)
Diabetes (196)
Diagnostics (6307)
Earnings (86798)
Employer resources (149)
Events (113365)
Executive appointments (527)
FDA (17339)
Funding (551)
Gene therapy (234)
GLP-1 (668)
Government (4466)
Healthcare (18924)
Infectious disease (2724)
Inflammatory bowel disease (118)
Interviews (320)
IPO (16691)
Job creations (4053)
Job search strategy (1489)
Layoffs (451)
Legal (8342)
Lung cancer (235)
Manufacturing (227)
Medical device (13330)
Medtech (13335)
Mergers & acquisitions (20205)
Metabolic disorders (531)
Neuroscience (1707)
NextGen: Class of 2025 (6632)
Non-profit (4521)
Northern California (1926)
Obesity (304)
Opinion (213)
Patents (141)
People (58671)
Phase I (20644)
Phase II (29297)
Phase III (21954)
Pipeline (636)
Postmarket research (2653)
Preclinical (8744)
Radiopharmaceuticals (245)
Rare diseases (311)
Real estate (6245)
Regulatory (22674)
Research institute (2360)
Resumes & cover letters (358)
Southern California (1666)
Startups (3717)
United States (17351)
Vaccines (605)
Weight loss (216)
Date
Today (152)
Last 7 days (634)
Last 30 days (2587)
Last 365 days (35358)
2025 (2587)
2024 (35770)
2023 (40630)
2022 (51797)
2021 (56329)
2020 (54794)
2019 (47400)
2018 (35771)
2017 (33137)
2016 (32662)
2015 (38615)
2014 (32516)
2013 (27630)
2012 (29729)
2011 (30487)
2010 (28497)
Location
Africa (776)
Arizona (213)
Asia (40304)
Australia (6453)
California (4411)
Canada (1602)
China (377)
Colorado (200)
Connecticut (211)
Europe (85835)
Florida (635)
Georgia (154)
Illinois (438)
Indiana (256)
Maryland (704)
Massachusetts (3435)
Michigan (190)
Minnesota (322)
New Jersey (1251)
New York (1265)
North Carolina (816)
Northern California (1926)
Ohio (161)
Pennsylvania (1028)
South America (1159)
Southern California (1666)
Texas (650)
Utah (129)
Washington State (441)
710,262 Results for "astex pharmaceuticals inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Genetown
Astex Pharmaceuticals Announce Key Data Presentations at the American Association For Cancer Research (AACR) 2024 Annual Meeting
Astex Pharmaceuticals announced that it will make five key data presentations at AACR 2024 focusing on its Phase II-ready MDM2 antagonist, ASTX295.
April 3, 2024
·
3 min read
Press Releases
Astex Pharmaceuticals Announce Key Data Presentations at the 36th EORTC-NCI-AACR Symposium
October 21, 2024
·
4 min read
Biotech Bay
Taiho Oncology and Astex Pharmaceuticals Announce Data Presentations at the 65th ASH Annual Meeting
Taiho Oncology Inc. and Astex Pharmaceuticals, Inc. announced today details of studies to be presented at the 65th American Society of Hematology (ASH) Annual Meeting, to be held Dec. 9-12, 2023, in San Diego.
November 17, 2023
·
5 min read
Genetown
Astex Expands Drug Discovery Collaboration With MSD
Astex Pharmaceuticals announced an exclusive worldwide research collaboration and license agreement with MSD.
August 8, 2023
·
2 min read
Policy
Otsuka and Astex announce that the European Commission has approved INAQOVI® (oral decitabine and cedazuridine) for the treatment of adults with newly diagnosed acute myeloid leukaemia
Otsuka Pharmaceutical Europe Ltd. and Astex Pharmaceuticals, Inc. announce that the European Commission has approved INAQOVI® as monotherapy for the treatment of adult patients with newly diagnosed acute myeloid leukaemia who are ineligible for standard induction chemotherapy.
September 19, 2023
·
7 min read
Business
Third Success from Astex Drug Discovery Pharma Collaboration and Licence Agreements as AstraZeneca Receives US Marketing Approval for Cancer Drug Truqap (capivasertib)
Astex Pharmaceuticals announced that it is in line to receive a milestone payment from AstraZeneca on first commercial sale of the drug in the US and royalties from AstraZeneca on future sales following the US Food and Drug Administration’s approval of Truqap™ plus Faslodex® as a treatment for adult patients with HR-positive, HER2-negative locally advanced or metastatic breast cancer with one or more biomarker alterations.
November 20, 2023
·
4 min read
Press Releases
Conduit Pharmaceuticals Inc. Announces Reverse Stock Split
January 23, 2025
·
5 min read
Press Releases
Immedica to Acquire Biopharmaceutical Company Marinus Pharmaceuticals, Inc.
December 30, 2024
·
11 min read
Press Releases
HOPE Therapeutics™, Inc. and NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announce Signing of Binding Term Sheet for $27 Million in Funding for HOPE Clinic Acquisitions and Pharmaceutical Operations
January 7, 2025
·
8 min read
Press Releases
HOPE Therapeutics™, Inc. and NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Execute Agreement for $27 Million Funding Transaction for HOPE Clinic Acquisition
January 28, 2025
·
8 min read
1 of 71,027
Next
